Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 117 results found. Search for [ NPPA ]

Results 1 to 21 of 117
BusinessToday.In
August 25, 2019
In September last year, a committee on National List of Essential Medicines (NLEM) had set up sub-committees to classify medicines, medical devices, disposables, and health and hygiene products as per their criticality for the healthcare.


PB Jayakumar
New Delhi, May 28, 2019
Domestic cancer drug sales are growing at 20 per cent annually for the past few years, while global growth is half of that


E Kumar Sharma
New Delhi, May 23, 2019
The pharma industry is today growing at around 11 per cent per annum as compared to a high of around 15 per cent about five years ago.


BusinessToday.In
New Delhi, May 17, 2019
In March, the rates were brought down for around 380 drugs, with some cuts going to as much as 80-90 per cent under trade margin rationalisation.


BusinessToday.In
New Delhi, May 14, 2019
The lawsuit accuses Teva Pharmaceuticals USA Inc of orchestrating a sweeping scheme with 19 other companies to inflate drug prices, by more than 1,000% in some cases


BusinessToday.In
May 9, 2019
In as many as 666 cases, pharma companies are yet to disgorge excess profits accrued by overcharging customers under the Drug Prices Control Orders. The DoP has now made a one-time settlement offer on their total outstanding dues, provided they collectively cough up Rs 3,501 crore and drop their lawsuits


PTI
April 1, 2019



PTI
April 1, 2019



PTI
April 1, 2019



Joe C Mathew
New Delhi, March 19, 2019
In early March, the National Pharmaceutical Pricing Authority (NPPA), India's drug price regulator, fixed the ceiling prices of 463 brands of cancer medicines.


PTI
February 27, 2019



PTI
February 27, 2019



PTI
February 27, 2019



PTI
February 17, 2019



PTI
January 27, 2019



PTI
January 23, 2019



PTI
December 18, 2018



PTI
November 20, 2018



Renu Yadav
November 20, 2018
The fund house believes that these are interesting times for Indian healthcare sector despite disappointing earnings in FY18. The sector has the potential to get re-rated after temporary disruptions get resolved


PTI
November 2, 2018



PAGES 1 OF 6  12345